AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-106007447/chart-watch-biotech-firm.html" title="Facts and information about CHART WATCH Biotech Firm Closer To Passing Its Pivot.(B)(NASDAQ STOCKS IN THE NEWS)">CHART WATCH Biotech Firm Closer To Passing Its Pivot.(B)(NASDAQ STOCKS IN THE NEWS)</a>
Close
Set up an RSS feed that alerts you when new articles from Investor's Business Daily are available.
Frequently asked questions about RSS feeds
CHART WATCH Biotech Firm Closer To Passing Its Pivot.(B)(NASDAQ STOCKS IN THE NEWS)
Byline: Monika Tjia
In June, Idec Pharmaceuticals attempted to clear a 24-week base but failed. Since then it has formed a six-month base, sitting 9% off its high.
In the past nine weeks its Relative Price Strength Rating has ranged from 52 to 89. It's now 79.
The biotech firm develops treatments for cancer and autoimmune and inflammatory diseases. It makes Rituxan, a drug that treats non-Hodgkin's lymphoma.
Profit growth has hit 43% or higher in the past five quarters. Analysts predict 2001 earnings will rise 64% vs. 24% a year ago, says First Call.
Sales growth has been 42% ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- City biotech firm closer to goal
- Newspaper article from: Winnipeg Free Press Cash, Martin August 11, 2009 700+ words
Anti-bacterial gel step toward approval of company's enzyme KANE Biotech is one step closer in its efforts to develop a treatment to unlock bacteria suspended in biofilm that are 1,000 times more resistant than normal bacteria. The Winnipeg company teamed up with a contract manufacturer in Prince
- Biotech firm cuts loss with tests near.(Business)
- Newspaper article from: The Washington Times Tai, Jennifer November 12, 1996 700+ words
The prospect of the first human clinical tests has moved a Rockville biotech firm closer to profitability. Human Genome Sciences Inc. reported a net loss of $5.2 million (28 cents per share) for the third quarter...
- Biotech Firm Streamlines Administrative Processes and Manages Growth with...
- Press release article from: PR Newswire December 18, 2002 700+ words
...announced that Invitrogen, an international biotech firm that provides essential technologies...out UltiPro's workforce portal. The biotech firm plans to roll out UltiPro's self...and scalability needed to grow as the biotech firm prepares to integrate employees from...
- Biotech firm Ocimum to invest Rs 120cr for capital base, R & D.
- News wire article from: PTI - The Press Trust of India Ltd. December 16, 2006 700+ words
Biotech firm Ocimum to invest Rs 120cr for capital base, R & D Hyderabad, Dec 16 (PTI) Biotech firm Ocimum Biosolutions today said it would invest Rs 120 crore towards overseas acquisition and improving its capital base, Research and...
- A biotech firm with its eyes on the prize.(Targeted Industries Growth...
- Magazine article from: Hawaii Business Youn, Jacy L. February 1, 2005 700+ words
...year and a half, ever since he formed the Moiliili-based biotech firm, Cellular Bioengineering Inc. (CBI) in mid-2003. But...transplantation for Parkinson's Disease. For the small, obscure biotech firm nestled in the environs of Moiliili, it's all very exciting...
- Polish biotech firm Bioton aims for 5% share of world insulin market in '07 on...
- Newspaper article from: Poland Business News January 6, 2006 700+ words
Polish biotech firm Bioton aims for 5% share of world insulin market in '07 on expansion WARSAW. JANUARY 6. INTERFAX CENTRAL EUROPE - Polish listed biotech firm Bioton will boost its holding in the world insulin market from its...
- US biotech firm Genentech has urged its shareholders not to accept the latest...
- Magazine article from: Chemistry and Industry Eisberg, Neil February 23, 2009 700+ words
US biotech firm Genentech has urged its shareholders not to accept the latest bid by Swiss pharma major Roche of $86.5/share to acquire the 44.2% outstanding shares it does not hold in the biotech firm.
- Wisconsin Biotech Firm Claims Leap in Organ Transplant Research.
- Newspaper article from: Knight Ridder/Tribune Business News February 28, 2003 700+ words
...Business News Feb. 28--DeFOREST, Wis.--A Wisconsin biotech firm said Thursday that it has genetically engineered and cloned...minutes. Working with Immerge BioTherapeutics, a Boston biotech firm, Infigen was able to clone miniature swine with both of...
